6PUW image
Deposition Date 2019-07-18
Release Date 2020-02-12
Last Version Date 2024-03-20
Entry Detail
PDB ID:
6PUW
Title:
Structure of HIV cleaved synaptic complex (CSC) intasome bound with magnesium and Bictegravir (BIC)
Biological Source:
Method Details:
Experimental Method:
Resolution:
2.90 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Chimeric Sso7d and HIV-1 integrase
Gene (Uniprot):sso7d
Chain IDs:A, B, C, D
Chain Length:383
Number of Molecules:4
Biological Source:Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2), Human immunodeficiency virus 1
Polymer Type:polydeoxyribonucleotide
Molecule:viral DNA non-transferred strand
Chain IDs:E
Chain Length:27
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
Polymer Type:polydeoxyribonucleotide
Molecule:viral DNA transferred strand
Chain IDs:F
Chain Length:25
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
Primary Citation
Structural basis for strand-transfer inhibitor binding to HIV intasomes.
Science 367 810 814 (2020)
PMID: 32001521 DOI: 10.1126/science.aay8015

Abstact

The HIV intasome is a large nucleoprotein assembly that mediates the integration of a DNA copy of the viral genome into host chromatin. Intasomes are targeted by the latest generation of antiretroviral drugs, integrase strand-transfer inhibitors (INSTIs). Challenges associated with lentiviral intasome biochemistry have hindered high-resolution structural studies of how INSTIs bind to their native drug target. Here, we present high-resolution cryo-electron microscopy structures of HIV intasomes bound to the latest generation of INSTIs. These structures highlight how small changes in the integrase active site can have notable implications for drug binding and design and provide mechanistic insights into why a leading INSTI retains efficacy against a broad spectrum of drug-resistant variants. The data have implications for expanding effective treatments available for HIV-infected individuals.

Legend

Protein

Chemical

Disease

Primary Citation of related structures